Literature DB >> 11846499

Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.

P Della Bella1, R De Ponti, J A S Uriarte, C Tondo, C Klersy, C Carbucicchio, C Storti, S Riva, M Longobardi.   

Abstract

AIMS: Radiofrequency catheter ablation is effective at terminating ventricular tachycardia, but the overall clinical role of the technique in patients with a prior myocardial infarction is still debated, due to the uncertainties of the long-term reliability of the procedure. The purpose of this study was to prospectively investigate the relationship between acute results obtained by catheter ablation and long-term outcome in a homogeneous population of patients with post-myocardial infarction ventricular tachycardia. METHODS AND
RESULTS: One hundred and twenty-four consecutive patients with recurrent, drug-refractory, haemodynamically tolerated ventricular tachycardia were included in the study. This population accounted for 30% of the patients with post-myocardial infarction ventricular tachycardia admitted between April 1992 and September 1997 to the investigating centres. The ablation was successful in eliminating sustained ventricular tachycardia in 91 of them (73%); a partial result was obtained in 21 (17%) and failure in 12 (10%). Low dose amiodarone and/or beta-blockers were maintained in 86% of the patients. Over a median follow-up of 41.5 months (interquartile range 30.5-59.5 months), there were 15 deaths (12%), three of which were sudden (2.4%); the 12 remaining patients died of heart failure. Event-free survival analysis showed a significantly lower ventricular tachycardia recurrence rate in patients with a successful procedure as compared to those with failure or a partial result (19% vs 53% at one year and 27% vs 60% at 3 years, P=0.003). A repeat procedure was performed in 15 patients with early recurrences and was followed in all by long-term success. Of those who submitted to a second procedure, 93/124 patients (75%) are free of ventricular tachycardia recurrences. An implantable cardioverter-defibrillator (ICD), following procedure failure, was implanted in 13 patients (11%) of the study population.
CONCLUSIONS: Radiofrequency catheter ablation is effective in a wide population of patients with recurrent tolerated ventricular tachycardia, with very low sudden death and cardiac mortality rates over the long-term. Persistent ventricular tachycardia inducibility after catheter ablation requires an ICD implant and/or repeat ablation. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846499     DOI: 10.1053/euhj.2001.2804

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  16 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

Review 2.  A Questionable Indication For ICD Extraction After Successful VT Ablation.

Authors:  Luca Segreti; Andrea Di Cori; Giulio Zucchelli; Ezio Soldati; Giovanni Coluccia; Stefano Viani; Luca Paperini; Maria Grazia Bongiorni
Journal:  J Atr Fibrillation       Date:  2015-04-30

3.  Role of catheter ablation of ventricular tachycardia associated with structural heart disease.

Authors:  Roberto De Ponti
Journal:  World J Cardiol       Date:  2011-11-26

4.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

5.  Ventricular tachycardia inducibility after radiofrequency ablation affects the outcomes in patients with coronary artery disease and implantable cardioverter-defibrillators: The role of left ventricular function.

Authors:  Andrea Colella; Marzia Giaccardi; Raffaele Molino Lova; Carmine Liccardi; Gian Franco Gensini
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

Review 6.  Catheter ablation of ventricular tachycardia in patients with ischemic heart disease.

Authors:  Kyoko Soejima; William G Stevenson
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

7.  Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction.

Authors:  Ian D Greener; Tetsuo Sasano; Xiaoping Wan; Tomonori Igarashi; Maria Strom; David S Rosenbaum; J Kevin Donahue
Journal:  J Am Coll Cardiol       Date:  2012-08-08       Impact factor: 24.094

Review 8.  Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.

Authors:  Jonathan Weinstock; Paul J Wang; Munther K Homoud; Mark S Link; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

9.  Functional pace-mapping responses for identification of targets for catheter ablation of scar-mediated ventricular tachycardia.

Authors:  Roderick Tung; Nilesh Mathuria; Yoav Michowitz; Ricky Yu; Eric Buch; Jason Bradfield; Ravi Mandapati; Isaac Wiener; Noel Boyle; Kalyanam Shivkumar
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-02-14

10.  Limitations and Challenges in Mapping Ventricular Tachycardia: New Technologies and Future Directions.

Authors:  Adam J Graham; Michele Orini; Pier D Lambiase
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.